Catalyst Wire Dossier Catalyst Wire Dossier

OLOPATADINE HCL

OLOPATADINE HCL · Sola Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OLOPATADINE HCL, covering 2015-12-07 to 2021-04-02. Get the full timeline:

Most recent: FDA Approved: OLOPATADINE HCL — Supplemental Application (Sola Pharmaceuticals)

See pricing